Methodological Challenges in the Economic Evaluation of a Gene Therapy for RPE65-Mediated Inherited Retinal Disease: The Value of Vision
Previous
Previous
Guidance for the Harmonisation and Improvement of Economic Evaluations of Personalised Medicine
Next
Next